chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got COVID-19 6 months after my vaccine. I tested positive for 04/01/2023. I had fever and flu like symptoms, cough. I still have a cough and some congestion. I also tested negative on 04/10/2023.
About 40 hours after vaccine child awoke with red, swollen, sore to touch spot in area of vaccine - 5 cm in diameter, came to doctor; recommended cold, BENADRYL and watch it. Resolved in 24-48 hrs.
patient felt quite sick with definite flu symptoms within 2 days; sore arm; Initial information received on 06-Dec-2020 regarding an unsolicited valid non-serious case from a non-health care professional via social media.  This case was linked with 2020SA353023 and 2020SA353034 (same reporter).  This case involves a female patient with an unknown age who felt quite sick with definite flu symptoms within 2 days (illness) and sore arm (Myalgia), while being received vaccine influenza vaccine.  Medical history, past medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date (latency: unknown) after starting the suspect vaccine therapy, the patient felt quite sick with definite flu symptoms within 2 days (illness) and sore arm (Myalgia) (latency unknown).   No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
pt recv vax&exp skin rash;pharmacist reported that he felt the pt did not devel an adverse rxn to the vax;he stated the pt devel a clinical of wild type virus verified by contact w/a friend
Second day through day five: varying and intermittent flu symptoms - chills, joint pain, muscle pain, bone pain, headache leg spasms/pain, cramping same as DVT symptoms
No additional AE reported; Patient was administered expired PROQUAD; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 12-APR-2022, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose and route were not reported; lot # T034825, expiration date: 11-APR-2022) for prophylaxis (expired product administered).     No additional adverse event (AE) was reported (no adverse event).
approx 6 hr p/vax pt exp chills, cold sweat, h/a, blurred vision, nausea, dizziness, fever, gen muscle & joint pain;
After my second shot on March 1, I suffered a brain bleed on March 27 on both sides of my brain and was hospitalized in the Surgical Neurological ICU for 5 days and in a step-down neurology room for 1 day.  The medical professionals have been unable to determine the cause of the brain bleed except for the fact that my blood pressure (which was always low to normal) was over 200.  While hospitalized and since hospitalization I have had to take blood pressure medicine to control the numbers.  I have made great strides in overcoming the results of the stroke in the last 5 months.  I see a question below that says have I recovered.  My answer is not yes, no, or unknown.  My answer is mostly.  I will, however check yes below.
Headache, Fever, chills, fatigue Narrative:  Other Relevant History:
11AM, 05/31/2003, woke up with red rash on left arm only.  By AM rash had progressed to rest of body including soles of feet.  Temperature 101 rectal.  Tylenol given every 4 hours.  Saw MD with diagnosis probable virus, gave cream to apply on 06/04/2000.
Chills - High Fever - Aches (my whole body hurt) - Lethargic - Headache - swelling, redness, and pain at the injection site
Patient passed out on the ground as she was walking to us to inform the staff that she isn't feeling well. EMS was contacted but she refused to be taken to the hospital with them. Her parents were present and followed her home. She claimed that she suffers from chronic anxiety
Patient was given KINRIX (DTaP/IPV) on 8/20/18 in left thigh. Came in 8/22/18 red spot measuring 5 cm. No complaints, just redness.
Pt received below vaccines at 1000 01/05/04. At 1500 pt states she started feeling tired, at 1800 pt was eating dinner. She states she was having trouble swallowing. At 2100 she states she was having trouble breathing. She looked in her throat from back of tongue there were large bumps. At this time she states she took Benadryl 4 teaspoons liquid. Pt states at 2130 she was able to breathe comfortably again. She states she still has the large bumps in her throat.
vaccine expired on 2-2-23, not 3-2-23  No adverse event
Patient reports she began to experience itchy eyes and chest congestion 3 hours after receiving vaccine.  She took Benadryl which relieved symptoms.  The vaccine was latex-free, and all supplies were latex-free.
Patient came to ED was found to have Covid and was sent home on Paxlovid.  Patient returned to the ED 3 days later complaining of muscle aches, generalized weakness, nausea and vomiting.  She was admitted with Covid pneumonia and treated with remdesivir.
Patient arrived at the vaccination Center for a Moderna Booster (Previous Janssen Vaccine). In the observation area she began with redness and itching on her R wrist and palm and then on L wrist and palm. Her vaccine was administered in her L Deltoid. The Patient was evaluated, and VS were obtained. The patient, at no time, exhibited signs of shortness of breath, swelling or Anaphylaxis. However, the patient was very uncomfortable with the itching. Pt was administered Benadryl 50 mg PO and asked to stay a full 30 min observation time. EMS was offered and the patient respectfully refused.  Pt Hx HTN. RX for HTN nos and Paxil Allergy- PCN?s 1018-BP 124/82 P58 reg R16 unlabored Spo2 97% RA 1020- Benadryl 50MG PO 1032-BP 117/80 P 56 reg R 14 unlabored Spo2 96% RA Pt states her rash is feeling much better. The patient was advised to call 911 if severe symptoms occur (including shortness of breath, swelling and persistent hives) and to follow up with Benadryl and her Doctor as needed. She again, was offered EMS and kindly, refused. Pt left the vaccination center at approximately 1045.
tachycardia up to 190 bpm, shortness of breath, hypoxia, fever, sweat, weakness.
This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL PAIN (I had severe sharp pain in stomach and intestinal tract for 24 hours, kept me up all night, next day was intermittent), CHILLS (Started next morning chills, fatigue, nausea), FATIGUE (Started next morning chills, fatigue, nausea) and NAUSEA (Started next morning chills, fatigue, nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The patient's past medical history included Blood pressure high since an unknown date. Concurrent medical conditions included Hypercholesteremia (High cholesterol). Concomitant products included POTASSIUM and VITAMIN D NOS for an unknown indication. On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL PAIN (I had severe sharp pain in stomach and intestinal tract for 24 hours, kept me up all night, next day was intermittent), CHILLS (Started next morning chills, fatigue, nausea), FATIGUE (Started next morning chills, fatigue, nausea) and NAUSEA (Started next morning chills, fatigue, nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, GASTROINTESTINAL PAIN (I had severe sharp pain in stomach and intestinal tract for 24 hours, kept me up all night, next day was intermittent), CHILLS (Started next morning chills, fatigue, nausea), FATIGUE (Started next morning chills, fatigue, nausea) and NAUSEA (Started next morning chills, fatigue, nausea) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient took Tylenol and drank lots of water to relieve symptoms.
Fever, arm redness, pain and swelling, pain radiating into neck causing loss of movement.
Rheumatoid arthritis flare up; Elevated sedimentation rate; arthropathy, unspecified, involving shoulder region (sick on shoulder); This is a spontaneous report based on the information received by Pfizer. This report received from a contactable consumer (patient).   A female patient of an unspecified age received first dose of bnt162b2, intramuscularly on 17Mar2021 (Batch/Lot Number: FN6208FX; Expiration Date: Jun2021) as single dose, second dose intramuscularly on 20Apr2021 (Batch/Lot Number: ER8731) as single dose for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous from 2019 (Batch/Lot number was not reported) to May2021, at 40 mg (1 in 2 weeks), subcutaneous from May2021 (Batch/Lot number was not reported) and ongoing, at 40 mg, weekly (1 in 1 week) for rheumatoid arthritis. Medical history included tobacco Use from an unknown date to 1990 (stopped 1990), alcohol Use from an unknown date to 2000 (stopped 2000), sulfa drugs allergy manifestation by affects liver, methotrexate allergy manifestation by affects liver, anaemia, anxiety, pain, fibromyalgia, heart, restless legs, diabetes. Concomitant medications included metformin taken for diabetes, glipizide (GLIPIZIDE) taken for diabetes, dulaglutide (TRULICITY) taken for diabetes, ropinirole (ROPINIROLE) taken for restless legs, losartan taken for heart, carvedilol taken for heart, cyclobenzaprine taken for fibromyalgia, tramadol taken for pain, duloxetine taken for anxiety, colecalciferol (VITAMIN D), iron taken for anaemia. The patient experienced rheumatoid arthritis flare up on Apr2021, lack of drug effect/humira not working on May2021, elevated sedimentation rate on Apr2021, arthropathy, unspecified, involving shoulder region (sick on shoulder) on Apr2021. Adalimumab (HUMIRA) not working with Humira 40 mg/0.4 ml (Adalimumab). The patient was treated with prednisone. The action taken for adalimumab was dose increased. The outcome of events was not recovered.  Causality for Humira 40mg/0.4ml (Adalimumab): The reporter's causality for the event of elevated sedimentation rate was not provided. The reporter's causality for the events of rheumatoid arthritis flare up and sick on shoulder with Humira 40mg/0.4ml (Adalimumab) was no reasonable possibility. The reporter's causality for the event of Humira not working with Humira 40mg/0.4ml (Adalimumab) was a reasonable possibility.  Causality with bnt162b2: The reporter's causality for events elevated sedimentation rate and lack of drug effect was not reported, for events Rheumatoid arthritis flare up and Arthropathy, unspecified, involving shoulder region (sick on shoulder) was Possible related.  No follow-up attempts are needed. No further information is expected.
very sleepy; sick; slight headache; chills; tiredness; pain in her stomach/my stomach hurt; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), ILLNESS (sick), SOMNOLENCE (very sleepy), NAUSEA (nauseous) and HEADACHE (slight headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer. Concomitant products included LOSARTAN and AMLODIPINE for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), NAUSEA (nauseous), CHILLS (chills) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced ILLNESS (sick) and HEADACHE (slight headache). On an unknown date, the patient experienced SOMNOLENCE (very sleepy). On 01-Mar-2021, ILLNESS (sick), NAUSEA (nauseous), HEADACHE (slight headache), CHILLS (chills) and FATIGUE (tiredness) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt) had not resolved and SOMNOLENCE (very sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list also included Trazadone 5mg. Treatment information included Tylenol.
sl fever, started Sunday day 8 balance problem complaint in the legs, jerking w/steps;@ site of hep b had bruise area size of a dime in middle of area-pin head size bump;congestion in lungs;diarrhea, walking like cripple;
Having pain and tightness below my left knee in inner calf wondering if a blood clott - not typical nor have I ever experienced this before.
Not able to get the 2nd shot in the recommended timeframe; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not able to get the 2nd shot in the recommended timeframe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not able to get the 2nd shot in the recommended timeframe). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not able to get the 2nd shot in the recommended timeframe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.
I had a brain stroke on 2/23/2022, which affected my short term memory and speech. The headaches I get are massive.
Hard time to Urinate; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Hard time to Urinate) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer. Concomitant products included MORNIFLUMATE (FLOMAX [MORNIFLUMATE]) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DYSURIA (Hard time to Urinate). At the time of the report, DYSURIA (Hard time to Urinate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
On 10/06/2010 developed fever of 102.7. Next day developed cough and sneezing, along with lethargy. On evening of 10/12/2010 experienced 2 episodes of vomiting. Fever and lethargy are still present as of 10/15/2010.
Was not feeling well prior to shot (nauseated). 2hrs after shot, vomiting and sweating a drop in temp. (96.1F) continued for 3-4 days. Patient feels this may be a coincidence. PCP Doctor would like reported as well.
Information has been received from a pharmacist concerning a 72 year old male who on 27-NOV-2007 was vaccinated with Zostavax (Oka/Merck) (Lot #658839/1411U) 0.65 mL SC in the left arm.  There was no concomitant medication.  On approximately 11-DEC-2007 the patient developed a raised, itchy, red rash on his left arm, which covered the entire upper arm from the shoulder to the elbow.  The patient's raised, itchy red rash persisted.  The patient sought medical attention.  Additional information has been requested.  Follow-up information has been received from the responsible physician concerning a 72 year old male with arteriosclerotic heart disease, benign prostatic hypertrophy and glaucoma who on 27-NOV-2007 was vaccinated with Zostavax (Oka/Merck) (Lot #658839/1411U) 0.65 mL SC in the left arm.  Concomitant therapy included INFLUENZA VIRUS VACCINE USP administered the "prior month."  In December 2007, one week after the vaccination, the patient developed a sore, swollen and red left arm at site of the injection.  Then (date not provided) the patient developed a papular rash on the left and right biceps and thighs.  The patient sought medical attention.  There was no product quality complaint.  Outcome of the sore, swollen, red left arm was not provided; however, the papular rash persists and "is now slowly clearing."  Additional information is not expected.
From the time she received the vaccine she has experienced pain that has radiated to the left side of her neck and down her left arm. She is also experiencing tingling (still) in her left arm. The pain has gotten progressively worse each day. She has been to one physician already, and is currently on her way to the ER for further treatment.
This spontaneous report as received from a physician refers to a patient of unknown age (gender was unknown and it was not sure if the patient was a child or an adult). On an unknown date the patient was vaccinated with a dose of VARIVAX (lot #, dose and route not reported). On an unknown date the patient developed chickenpox after receiving VARIVAX (Merck). The outcome of the event was unknown. This is one of several reports from same source. Additional information is not expected.
Pt's father phones with report of red tissue around injection site 3/21/03. Resolved on 3/22/03. Pt not brought to clinic. Advised per phone of treatment cold compress and Tylenol for discomfort.
Upset Stomach. Diarrhea. Left side of nose started to hurt  and burn (same side of vaccine) immediately after vaccination for 10 minutes following.
Patient first noticed left deltoid soreness upon laying down in bed on Friday (9/20/19) night. Upon awakening the next morning, the patient then noticed patchy spots on his left deltoid that displayed some redness and swelling. The patient's wife informed pharmacy staff of this adverse event, and upon further questioning, it was discovered that the patient has been experiencing some pain, which is tolerable, and some itching at injection site. Patient and his wife have been closely monitoring this adverse reaction and stated that they will go to the doctor if the patient's condition worsens at any time. Patient's wife has used some benadryl (oral and topical cream) to relieve some of the itching.
ED to Hosp-Admission Current   8/2/2021 - present (14 days) the Hospital Chief Complaint Patient presents with ? Shortness of Breath  Sepsis secondary to pneumonia, presenting with tachypnea and leukocytosis and acute kidney injury Community-acquired pneumonia versus COVID-19 pneumonia ?Admit to medical service
lip swelling or inflammation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lip swelling or inflammation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (lip swelling or inflammation). At the time of the report, LIP SWELLING (lip swelling or inflammation) outcome was unknown.            No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Arm was sore where she got the shot for a few days after the Vaccine; body aches and pains/pain; stayed in bed all day/has not had energy; not feeling good; sick; basically flu like symptoms; fogginess; vomiting; forgetfulness; chills; migraine headache; severe sinus issues; diarrhea; nausea; high fever; This is a spontaneous report from a contactable consumer (patient's friend). This consumer reported similar events for three patients. This is the third of three reports.  A 68-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration in left arm on an unspecified date as single dose for covid-19 immunisation. The patient received first dose of bnt162b2 (lot and expiry were not reported) on an unspecified date for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer (patient's friend) reported that the patient's symptoms only last 24hrs after the second shot the patient had the same symptoms as the consumer (friend), but no burning lungs, high fever, chills, migraine headache, severe sinus issues, diarrhea and nausea, all on 04Apr2021. On an unspecified date, arm was sore where she got the shot for a few days after the vaccine, body aches and pains/pain, stayed in bed all day/has no energy, not feeling good, sick, basically flu like symptoms that were worse than the flu, fogginess, vomiting and forgetfulness. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021377356 same reporter/drug, similar events, different patient.;US-PFIZER INC-2021372305 same reporter/drug, similar events, different patient.
painful; almost hard to move the arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (painful) and JOINT RANGE OF MOTION DECREASED (almost hard to move the arm) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ISOTRETINOIN (ACCUTANE) for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PAIN (painful) and JOINT RANGE OF MOTION DECREASED (almost hard to move the arm). At the time of the report, PAIN (painful) and JOINT RANGE OF MOTION DECREASED (almost hard to move the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported .
Pt fainted immediately while receiving vaccination. Regained consciousness quickly. Sweaty & pale. 5:45PM feeling alert & taking fluids.  BP120/78 P70 R16  Left w/o assistance.
Sore arm after shot. Fever, body aches same night into next day. (as expected)  Breakthrough bleeding started 2nd night after shot with full blown period starting 3rd morning after shot. She is on the pill, did not miss a dose and has never had breakthrough bleeding.  We are on day 3 so no known outcome resolution of bleeding.